Altogether, our results demonstrated that NCAPG2 contributes greatly to the development of NSCLC cell proliferation and leads to G2/M phase arrest, possibly through alterations of p27, p21 and G2/M phase cell cycle‐related protein expression (Cyclin B1, Cdc2). The gene discussed is NCAPG2; the disease is non-small cell lung carcinoma.